Susquehanna International Group, LLP Tiziana Life Sciences LTD Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 86,085 shares of TLSA stock, worth $191,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,085
Previous 57,330
50.16%
Holding current value
$191,969
Previous $61,000
122.95%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.61MCall Options Held
0Put Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI3.42MShares$7.62 Million9.57% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il199KShares$443,7470.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$234,9630.0% of portfolio
-
Zhang Financial LLC89.8KShares$200,1640.01% of portfolio
-
Hrt Financial LP New York, NY84.1KShares$187,5560.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $228M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...